Daiken Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	15,269	10,860	-	-
Enterprise Value	10,225	9,874	-	-
Last Close Price	188.50	172.57	-	-
PE Ratio	43.15	101.90	-	-
PS Ratio	8.56	7.97	-	-
PB Ratio	2.85	8.31	-	-
P/TBV Ratio	2.86	8.33	-	-
P/FCF Ratio	51.73	215.06	-	-
P/OCF Ratio	51.63	209.86	-	-
EV/Sales Ratio	5.74	7.25	-	-
EV/EBITDA Ratio	36.61	64.48	-	-
EV/EBIT Ratio	37.47	66.31	-	-
EV/FCF Ratio	34.64	195.53	-	-
Debt / Equity Ratio	0.00	0.00	1.12	0.60
Debt / EBITDA Ratio	0.07	0.01	1.35	1.21
Debt / FCF Ratio	0.07	0.05	2.63	3.27
Asset Turnover	0.48	1.19	1.87	-
Inventory Turnover	1.78	1.99	1.71	-
Quick Ratio	17.91	5.36	0.80	1.23
Current Ratio	19.43	6.56	1.64	2.17
Return on Equity (ROE)	8.09%	13.71%	67.55%	-
Return on Assets (ROA)	4.63%	8.15%	20.01%	-
Return on Capital (ROIC)	4.91%	10.15%	28.76%	-
Return on Capital Employed (ROCE)	5.10%	11.40%	68.80%	38.90%
Earnings Yield	1.76%	0.98%	-	-
FCF Yield	1.93%	0.46%	-	-
Dividend Yield	2.89%	2.34%	-	-
Payout Ratio	193.78%	2.89%	87.59%	-
Buyback Yield / Dilution	-77.82%	-95.20%	-44.34%	-
Total Shareholder Return	-74.87%	-92.86%	-44.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.